What Neulogy Ventures does

Neulogy Ventures is a Luxembourg-based regulated venture capital firm, established in 2014, that invests €200K to €3M in early-stage deeptech companies established or operating in Slovakia and the broader CEE region. The firm is structured as Neulogy Ventures S.à r.l., a registered alternative investment fund manager (AIFM) under CSSF oversight, serving as general partner of the Slovak Venture Fund S.C.A., SICAR. With €65 million in assets under management, the fund has built a portfolio of more than 30 companies across deeptech sub-sectors including B2B SaaS, Cleantech, Medtech, Cybersec, VR/XR, Fintech, and Marketplace. Portfolio companies span 10 countries, generate €122-135 million in aggregated annual sales, and have created over 1,250 jobs. The fund targets moonshot ideas in technology, climate, and health, leveraging CEE engineering talent and operating a hands-on model that combines capital with strategic guidance, business development support, fundraising assistance, and board participation.

The firm is anchored by institutional limited partners — the European Investment Fund (EIF), Slovak Investment Holding (SIH), and Tatra banka (RBI Group) — alongside 40+ key players in the Slovak entrepreneurial ecosystem. Revenue is generated through management fees calculated on subscription commitments or invested capital within SICAR compartments, supplemented by carried interest (special return) dependent on financial returns of those compartments. The core investment team comprises Managing Partner Christian Mandl (former SkyEurope co-founder and CEO, Maporama restructurer sold to TIBCO), Partner Jaroslav Luptak (tech-transfer specialist and StartupAwards.SK/FTRNW co-founder), Principal David Szedely, CFO Martin Smetana (former Deloitte Senior Manager), and Investment Manager Terezia Jacova. The portfolio demonstrates a mix of AI-enabled bets (Luigi's Box, StratifAI, Matsuko, BiteBerry, Trustmatic), enterprise SaaS (Staffino, Piano, Orderlord), cleantech (GreenWay, GA Drilling, SEAK), medtech (MultiplexDX, Mentegram, Anvesana, Diagnose.me), and marketplace platforms (Eyerim, Meet'n'learn, Invesdor, Solved), with documented exits including Trustmatic's acquisition by Certn (2023), Orderlord's acquisition by REEF Technology (2020), and SaferPass (2022). The firm is GDPR- and SFDR-compliant and holds memberships in SAPIE, Invest Europe, and the Slovak Venture Capital Association (SlovCA).

Name

Neulogy Ventures

Legal name

Neulogy Ventures, a.s.

Website

https://neulogy.vc

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Neulogy Ventures is a Luxembourg-regulated venture capital firm investing €200K-€3M in early-stage deeptech companies across Slovakia and CEE, managing €65M in AUM across 30+ portfolio companies in technology, climate, and health sectors.

Ownership category

akta.pro rank

Product category

Venture Capital Fund Management

NAICS

Other Financial Investment Activities (5239), Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (523940)

SIC

Investors, Nec (6799)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital investing
• Deeptech investments
• Early-stage funding
• Fund management services
• Startup portfolio management

Headquarters

HQ city

Bratislava

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Management Fees: Management fee payable by certain compartments in the SICAR, calculated on subscription commitments during investment period or on invested capital, subject to a cap.
2. Carried Interest (Special Return): Affiliates of Neulogy Ventures S.à r.l are entitled to receive a special return dependent on the financial returns of certain compartments in the SICAR.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Neulogy Ventures is a Luxembourg-based venture capital firm that manages the Slovak Venture Fund S.C.A., SICAR, a regulated alternative investment fund investing equity capital in early-stage deeptech companies across Slovakia and the broader Central and Eastern European region. The firm holds €65M in assets under management, has backed more than 30 portfolio companies, and writes equity tickets of €200K to €3M into moonshot ideas in technology, climate, and health. Beyond capital, partners provide strategic guidance, board representation, and follow-on financing support to portfolio founders.

Product overview

Neulogy Ventures operates as a Luxembourg-based venture capital firm with a diversified portfolio of 30+ portfolio companies spanning multiple technology sectors including B2B SaaS, Cleantech, Medtech, VR/XR, Cybersec, Marketplace, Fintech, and Infrastructure. The portfolio includes AI-powered solutions (Luigi's Box for e-commerce search, Matsuko for holographic presence, GroupSolver for market research), advanced technologies (Vectary 3D modeling, StratifAI oncology diagnostics, GA Drilling geothermal), and various platforms (Piano content monetization, Invesdor fintech, Solved sustainability marketplace). Rather than a single unified product, Neulogy Ventures manages a portfolio of independent companies, each offering distinct products and services across deeptech, climate, and health sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• Slovak Venture Fund S.C.A., SICAR CSSF-regulated venture capital fund that invests €200K–€3M equity tickets in early-stage deeptech companies in Slovakia and the broader CEE region. Targeted at institutional limited partners and indirectly serving deeptech founders as investees.
• Direct equity investment and active portfolio support Equity capital plus strategic guidance, board representation, and follow-on financing for early-stage deeptech founders in Slovakia and CEE. Delivered to founding teams of deeptech startups in technology, climate, and health.

Quantifiable outcome

• 30+ portfolio companies with €122M aggregated annual sales
• +2 more outcomes

Named customers9 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability11 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Luxembourg CSSFcoreOthersRegulatory oversight by Luxembourg financial sector regulator CSSF, governing the Slovak Venture Fund S.C.A., SICAR structure.
• SAPIE (Slovak Alliance for Innovation and Entrepreneurship)minorOthersEcosystem membership organization supporting innovation and entrepreneurship in Slovakia.
• Invest EuropeminorOthersPan-European industry association for private equity and venture capital firms.
• SlovCA (Slovak Venture Capital Association)minorOthersNational industry association representing venture capital and private equity in Slovakia.
• LeasePlanminorStrategic or Co-development PartnerFleet leasing partner for Voltia Electric joint leasing solution matching monthly rentals of diesel vans with electric alternatives.
• Wayra PragueminorStrategic or Co-development PartnerOrderlord was selected as part of second batch of startups in Wayra Prague's accelerator program.
• Wayra Deutschland MunichminorStrategic or Co-development PartnerMeet'n'learn is a member of Wayra Deutschland in Munich, supporting geographic expansion.
• Dr. Thomas Tuschl LaboratorycoreStrategic or Co-development PartnerCore technology of Anvesana (RNA-sequence analysis pipeline) developed in Dr. Tuschl's laboratory. Technology licensed/integrated from academic research.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Credo: Already listed above as primary direct peer.
• Day One Capital: Budapest-based early-stage CEE tech VC. Similar regional focus, ticket size, and founder-friendly approach with comparable portfolio composition in B2B SaaS and digital platforms.
• Credo Ventures: Prague-based early-stage VC firm investing in CEE tech startups with similar ticket sizes and stage focus. Most directly comparable peer given overlapping geography, founder-friendly positioning, and portfolio overlap in CEE SaaS and deeptech.
• KAYA VC: Prague-based early-stage VC investing in CEE tech companies with sector focus on deeptech and B2B. Comparable ticket size and stage to Neulogy.
• LAUNCHub Ventures: Sofia-based early-stage VC focused on CEE tech founders. Directly comparable in geography and stage, with similar ticket sizes and B2B SaaS/tech thesis.

Regional players

• Venture to Future Fund (VtF): Slovak-affiliated VC backed by Slovak government and EIF, also investing in early-stage Slovak/CEE companies. Highly comparable given shared geographic focus and similar institutional backing ecosystem.
• Tera Ventures: Tallinn-based early-stage VC with CEE reach. Comparable in stage and tech focus, though with broader Baltic/Nordic orientation vs. Neulogy's CEE focus.

Others

• European Investment Fund (EIF): Anchor LP/institutional investor in Neulogy and many comparable CEE VC funds. As a fund-of-funds investor and LP secondaries participant, EIF is the most relevant ecosystem player shaping Neulogy's competitive landscape.

Broad incumbents

• Earlybird: One of Europe's oldest deeptech VCs with active CEE investments (e.g., GA Drilling co-investor). Comparable deeptech focus but significantly larger fund size and broader European mandate.
• Speedinvest: Vienna-based pan-European early-stage VC with multiple sector-focused funds including deeptech. Overlaps in CEE deal sourcing and stage, but operates with much larger AUM and broader sector coverage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/NeulogyVC
• LinkedInlinkedin.com/company/neulogy-ventures
• Facebookfacebook.com/NeulogyVentures

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments49 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neulogy Ventures